LINDE PLC (LIN): what the price assumes

In the published model solve dated 2026-Q2, anchored at $487.94, LINDE PLC (LIN) is priced for +18.4% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/LIN

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.4% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=17)

Solvency

Bullet Takeaways

• Linde is the world's largest industrial-gas company, and its economics rest on long-term on-site supply contracts that the 10-K describes as "long-term supply arrangements which generally require the customer to purchase their requirements from Linde" with minimum purchase and price-escalation terms, the structural source of its pricing power.
• The defining risk is the price itself: the stock trades at roughly 28 times company-wide operating income, at the very top of its peer distribution and beyond what any standard valuation family reaches.
• The next markers are quarterly margin and volume: Q1 FY2026 lifted operating margin to about 30% on pricing and productivity even as industrial volumes stayed soft in Europe and Asia, and management raised full-year EPS guidance, so watch whether price keeps doing the work that volume is not.

Bull Case

One number decides the Linde thesis, and it is the operating margin: about 26.5% on a trailing basis and roughly 30% in the most recent quarter, a level almost no company that sells a physical commodity ever reaches. Industrial gases are, on paper, a commodity, oxygen and nitrogen separated from air. Linde earns chemical-company volumes at software-adjacent margins, and if that margin holds, the entire premium valuation has a foundation. If it slips, the premium has nothing under it. Everything else in the bull case is an explanation of why that one number is durable.

The durability comes from contract structure, not from any secret in the chemistry. The 10-K describes Linde's relationships with its largest customers as "long-term supply arrangements which generally require the customer to purchase their requirements from Linde", arrangements with "minimum purchase requirements" and price-escalation provisions. A steel mill or semiconductor fab that takes its gas from an on-site Linde plant cannot easily switch: the plant is built next to the customer, the contract runs for years, and the price rises with cost by formula. That is take-or-pay revenue dressed as a commodity sale, and it is why Linde's most recent quarter could grow earnings on price and productivity even while volumes were flat. The filing adds a quiet edge: those on-site plants "also produce liquid products for the merchant market", so a single asset serves a contracted customer and an open market at once, and is "typically not dedicated to a single customer."

Capital discipline finishes the case. Return on equity runs around 18.4% against book value of $82.70 a share, the company converts roughly $5 billion a year into free cash flow, and share count has been shrinking about 2.3% annually, so the per-share base compounds without the company needing volume growth it cannot get from a mature industrial economy. Interest coverage near 16 times means the $22.6 billion of net debt is comfortably serviced. The bull case is not that Linde grows fast; it is that it earns an exceptional, contract-protected margin on a slow-growing base and returns the difference, which is precisely the profile that justifies a premium to the broad chemicals group it is sorted against.

Bear Case

Start with the qualitative truth before the ratio: there is no version of the standard analysis that calls Linde cheap, or even fairly priced. The bear case is not that the company is bad; it is that the price has detached from every method used to value it. The asset-value lens, the earnings-power lens, the peer-multiple lens, and even the forward-growth lens all read the stock as expensive, several of them by a factor of three or more. When no valuation family reaches the price, the stock is no longer being priced on its economics; it is being priced as a quality compounder the market refuses to let trade at a normal multiple, and that is a fragile equilibrium because it depends on sentiment about safety rather than on any cash flow the methods can find.

Translate the disconnect into the arithmetic. At roughly 28 times company-wide operating income, the price requires operating profit to grow about 21% a year for five years. Set that against a company that grew revenue about 5% in its base period and lifted earnings in its most recent quarter primarily through price and productivity rather than volume. The multiple sits at the very top of the peer distribution, well beyond the upper quartile, and only about 41% of comparable fast-growers historically sustained that pace for even five years. The earnings-power method, which capitalizes normalized operating profit with no growth credit, lands near a fifth of the price; the book-value-plus-profitability methods land near a third. If the premium multiple ever compresses toward where the static methods sit, the price has a long way to fall regardless of how well the business itself performs, because the business is not the problem; the multiple is.

The operating risk that could trigger that compression is demand. Linde's most recent results leaned on pricing precisely because industrial volumes were soft in Europe and parts of Asia-Pacific, and a company priced for 21% profit growth has no margin for a prolonged volume drought in its core regions. Pricing power is real but not infinite; cost-plus escalation defends margin, it does not manufacture the volume growth the multiple assumes. The balance sheet carries $22.6 billion of net debt, well-covered today, but it is the kind of leverage that turns from comfortable to constraining if a demand downturn coincides with the company needing to fund the large fixed capital its on-site model requires. The bear does not need Linde to stumble operationally. It only needs the market to decide that a top-of-cohort multiple on a mid-single-digit grower was too much.

Valuation

Linde is priced as if it were a high-growth company, and it is not one. At today's level the market pays roughly 28 times company-wide operating income, and inverting that price implies operating profit growth of about 21% a year for five years. The company's recent record is mid-single-digit revenue growth, with the most recent quarter's earnings gain coming from price and productivity rather than volume. The gap between what the price assumes and what the business delivers is the whole valuation: the price is not buying Linde's growth, it is buying Linde's certainty, and paying a high-growth multiple for it.

The method disagreement is unusually one-sided. No valuation family reaches the price. The forward-growth lens comes closest, with an exit-multiple DCF landing within range only by holding today's EV/EBITDA near 20 times flat for the forecast, but the perpetual-growth DCF, crediting Linde's actual roughly 5% growth, lands at less than half the price. The peer-multiple lens reads the stock as expensive against a blended sector P/E near 20 times. The earnings-power method, capitalizing normalized operating profit with no growth, sits near $110 against a market price above $500. And the asset-value methods land in the low-to-mid $200s, because even an 18.4% return on equity, capitalized properly, does not generate enough excess return over a $82.70 book value to support the price. The pattern is not ambiguous: every frame anchored on demonstrated economics says the price is a premium beyond what the methods support, and only a multiple held flat in perpetuity defends it.

The cohort comparison has to be read carefully, because the reported peer set, the commodity chemicals and fertilizer names like Dow, Eastman, CF Industries, and Mosaic, is not Linde's true economic peer group. Those businesses are cyclical price-takers; Linde is a contract-protected margin compounder, which is exactly why it trades at the top of that distribution and why a simple comparison to the group median understates how unusual its profitability is. The honest read is that Linde deserves a premium to commodity chemicals, but the size of the premium is the question, not the existence of it. Solvency is not the worry: net debt of $22.6 billion is covered roughly 16 times by operating profit, and the company funds its capital program from internal cash. The decisive fact is the multiple. The buyer at today's price is underwriting that the market keeps awarding Linde a top-of-cohort multiple on a business growing at the bottom of the growth range, indefinitely.

Catalysts

The Q1 FY2026 print was a clean beat-and-raise on the quality the bull cares about. Revenue rose 8.2% year over year to $8.78 billion, operating profit grew 8% to $2.6 billion at roughly a 30% margin, and management raised full-year EPS guidance to a $17.60 to $17.90 range with a Q2 outlook of $4.40 to $4.50. The composition of the beat is the story: management attributed it to pricing and cost productivity rather than broad volume growth, with margins improving about 50 basis points sequentially even as seasonal volumes declined.

That same composition names the catalyst risk. The earnings strength came despite weak industrial demand in Europe and parts of Asia-Pacific, and the company's own framing is that subdued conditions in those regions could pressure volumes if they persist. For a stock priced for 21% profit growth, the volume recovery in those core industrial regions is the swing variable, and it is the one Linde controls least. The pricing lever has carried earnings through the soft patch, but pricing escalation is a margin defense, not a growth engine, and the market is paying for growth.

The watch items are concrete and quarterly. Track whether operating margin holds near 30% as the pricing comparisons get harder, whether industrial volumes in Europe and Asia turn, and the pace of capital deployment into new on-site projects, since the long-term supply backlog is what converts today's capital into tomorrow's contracted, margin-protected revenue. Management's disciplined capital returns, the steady buyback and dividend, support the per-share math, but the print that would actually justify the multiple is one where volume rejoins price as a growth driver rather than substituting for it.

Peer Cohorts (Per Segment, With Filing Citations)

Engineering (reported)

• APD (AIR PRODUCTS AND CHEMICALS, INC.)
• FY2025 10-K: …natural gas, and hydrocarbon price fluctuations contractually through pricing formulas, surcharges, cost pass-through provisions, and tolling arrangements. Each of the regional industrial gases segments competes against global industrial gas companies as well as regional competitors. Competition in industrial gases…
• FY2025 10-K: …bulk and packaged gases do not include minimum purchase requirements, as they are governed by contracts and/or purchase orders that reflect the customer's specific needs. These contracts contain stated terms that are generally five years or less. We maintain inventory in locations that facilitate supply of products…
• DOW (Dow Inc.)
• FY2025 10-K: …The segment serves customers, brand owners and ultimately consumers in key markets including food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; mobility; and infrastructure. 5 Table of Contents The Company's unique advantages…
• FY2025 10-K: …UCARSOL ™ Amines and related technology for carbon capture and gas treating, ethanolamines, ethylene oxide ("EO"), ethyleneamines, ELEVATE ™ Additives for enhanced oil recovery, UCON ™ Fluids, DOWANOL ™ Glycol Ethers, DOWTHERM ™ Heat Transfer Fluids, DOWFROST ™ Fluids for data center cooling; higher glycols,…
• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …sites or for the transport of our products or raw materials; • chemical and oil spills; • discharges or releases of toxic or hazardous substances or gases; • shipment of incorrect or off-specification product to customers; • storage tank leaks; • other environmental risks; and • cyber-attack or other terrorist acts.…
• FY2025 10-K: …to technical support and customer service and are allocated to the other business segments. In 2025, 2024 and 2023 approximately 40% to 50% of all R&D costs were allocated to business segments other than Technology. 10 Table of Contents GENERAL Intellectual Property We maintain an extensive patent portfolio and…
• WLK (Westlake Corporation)
• FY2025 10-K: …and third quarters of the calendar year due to inventory restocking and improved weather for construction. Our sales are affected by the individual decisions of distributors and dealers on the levels of inventory they carry, their views on product demand, their financial condition and the manner in which they choose…
• FY2025 10-K: …opportunities. Depending on an employee's position and job responsibilities, these opportunities include safety training, technical courses, compliance training relating to company policies, business and professional development training, and professional growth classes. We also periodically conduct employee surveys…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …Engineered Materials business segment. The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses.…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …of hostilities or terrorism, cyber-attacks, or breakdown or degradation of transportation and supply chain infrastructure used for delivery of supplies to the Company or for delivery of products to customers. Unplanned disruptions of manufacturing operations or related infrastructure could be significant in scale and…
• FY2025 10-K: …difference between the carrying value of inventory and the estimated market value or net realizable value based upon assumptions about future demand and market conditions. For additional information, see Note 3, "Inventories". Properties Eastman records properties at cost. Maintenance and repairs are charged to…
• DD (DUPONT DE NEMOURS, INC.)
• FY2025 10-K: …expertise, supported by a portfolio of established brands, to advance new product and solution development. Details on Diversified Industrials 2025 net sales, by business and geographic region, are as follows: Building Technologies provides solutions for the non‑residential, residential, and repair‑and‑remodel…
• FY2025 10-K: …us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001666700 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueInputsLevel2Member…
• CC (Chemours Co)
• FY2025 10-K: …the cyclicality of key end markets, such as industrial, chemical processing, consumer goods, and transportation, and is expected to grow in line with GDP. However, with growing demand for cleaner and faster technologies, demand for products in the performance solutions portfolio is expected to grow at a rate faster…
• FY2025 10-K: …cc:TitaniumTechnologiesMember 2025-01-01 2025-12-31 0001627223 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember us-gaap:CrossCurrencyInterestRateContractMember cc:SeniorUnsecuredNotesEightPointZeroZeroZeroDueJanuaryTwoThousandThirtyThreeMember 2025-12-31 0001627223…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.